111 related articles for article (PubMed ID: 31091950)
1. Current view of treatment of hypoglycemia.
Brož J; Urbanová J; Nunes M; Tuháčková M; Brunerová L; Žďárská DJ
Vnitr Lek; 2019; 65(4):295-299. PubMed ID: 31091950
[TBL] [Abstract][Full Text] [Related]
2. Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.
Ranjan A
Dan Med J; 2018 Feb; 65(2):. PubMed ID: 29393039
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
[TBL] [Abstract][Full Text] [Related]
5. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Pontiroli AE; Ceriani V
Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
[TBL] [Abstract][Full Text] [Related]
6. Severe Hypoglycemia Before Landing in a Patient with Type 1 Diabetes Using Sensor-Augmented Pump Therapy.
Viñals C; Pané A; Quirós C; Giménez M; Conget I
Diabetes Technol Ther; 2017 Aug; 19(8):491-492. PubMed ID: 28594566
[No Abstract] [Full Text] [Related]
7. Hypoglycemia: New Definitions and Regulatory Implications.
Ratner RE
Diabetes Technol Ther; 2018 Jun; 20(S2):S250-S253. PubMed ID: 29873525
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
[TBL] [Abstract][Full Text] [Related]
9. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
[TBL] [Abstract][Full Text] [Related]
10. Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.
Ranjan A; Schmidt S; Damm-Frydenberg C; Steineck I; Clausen TR; Holst JJ; Madsbad S; Nørgaard K
Diabetes Care; 2017 Jan; 40(1):132-135. PubMed ID: 27797928
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
[TBL] [Abstract][Full Text] [Related]
12. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.
Seaquist ER; Dulude H; Zhang XM; Rabasa-Lhoret R; Tsoukas GM; Conway JR; Weisnagel SJ; Gerety G; Woo VC; Zhang S; Carballo D; Pradhan S; Piché CA; Guzman CB
Diabetes Obes Metab; 2018 May; 20(5):1316-1320. PubMed ID: 29504662
[TBL] [Abstract][Full Text] [Related]
13. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients. The GL-G Hypoglycemia Study Group.
Namba M; Hanafusa T; Kono N; Tarui S
Diabetes Res Clin Pract; 1993 Feb; 19(2):133-8. PubMed ID: 8472628
[TBL] [Abstract][Full Text] [Related]
15. Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes.
Moutairou A; Roussel R; Charbonnel B; Leye A; Detournay B; Mohammedi K; Potier L
Diabetes Metab; 2017 Sep; 43(4):392-394. PubMed ID: 28161368
[No Abstract] [Full Text] [Related]
16. Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus.
White M; Zacharin MR; Werther GA; Cameron FJ
Pediatr Diabetes; 2016 Feb; 17(1):66-9. PubMed ID: 25229989
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA
Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Glucagon for Severe Hypoglycemia.
Grant JS; Graven LJ
Home Healthc Now; 2017 Feb; 35(2):114-115. PubMed ID: 28157777
[No Abstract] [Full Text] [Related]
19. Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes.
Belfort-DeAguiar RD; Naik S; Hwang J; Szepietowska B; Sherwin RS
Diabetes Care; 2015 Sep; 38(9):1736-41. PubMed ID: 26153273
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
Rossetti P; Porcellati F; Bolli GB; Fanelli CG
Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
